Monitoring Therapeutic Response in a Case of Extrapulmonary Tuberculosis by Serial F-18 FDG PET/CT

被引：8

作者：

Park Y.H. ^{[1
]}

Yu C.M. ^{[1
]}

Kim E.S. ^{[2
]}

Jung J.O. ^{[1
]}

Seo H.S. ^{[1
]}

Lee J.H. ^{[1
]}

Hur S.C. ^{[1
]}

Kim S.Y. ^{[1
]}

Lee H.Y. ^{[1
]}

机构：

[1] Department of Internal Medicine, National Police Hospital, Songpa Gu, Seoul 138-708, Ga-rak Bon Dong

[2] Department of Nuclear Medicine, National Police Hospital, Seoul

来源：

Nuclear Medicine and Molecular Imaging | 2012年 / 46卷 / 1期

关键词：

Extrapulmonary tuberculosis; F-18 FDG PET/CT; Tuberculosis;

D O I：

10.1007/s13139-011-0114-8

中图分类号：

学科分类号：

摘要：

Due to the low yield of AFB smear and culture in extrapulmonary tuberculosis, therapeutic responses of patients with extrapulmonary tuberculosis are usually monitored clinically and/or radiographically. Such monitoring techniques, however, are not enough to provide effective diagnosis if a remnant lesion exists after treatment. Tuberculosis presents hypermetabolic activity on F-18 fluorodeoxyglucose positron emission tomography/computed tomography (F-18 FDG PET/CT) scanning. Reported herein is a case of extrapulmonary tuberculosis where the therapeutic response was assessed via serial F-18 FDG PET/CT scanning, which was useful for detecting the extent of extrapulmonary tuberculosis and for estimating the patient's therapeutic response. © 2011 Korean Society of Nuclear Medicine.

引用

页码：69 / 72

页数：3

共 16 条

[1] Blumberg H.M., Burman W.J., Chaisson R.E., Daley C.L., Etkind S.C., Friedman L.N., Et al., American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis, Am J Respir Crit Care Med, 167, pp. 603-662, (2003)
[2] Ong A., Creasman J., Hopewell P.C., Gonzalez L.C., Wong M., Jasmer R.M., Et al., A molecular epidemiological assessment of extrapulmonary tuberculosis in San Francisco, Clin Infect Dis, 38, pp. 25-31, (2004)
[3] Phillips P.P., Davies G.R., Mitchison D.A., Biomarkers for tuberculosis disease activity, cure, and relapse, Lancet Infect Dis, 10, pp. 69-70, (2010)
[4] Makis W., Abikhzer G., Stern J., Tuberculous synovitis of the hip joint diagnosed by FDG PET-CT, Clin Nucl Med, 34, pp. 431-432, (2009)
[5] Park I.N., Ryu J.S., Shim T.S., Evaluation of therapeutic response of tuberculoma using F-18 FDG positron emission tomography, Clin Nucl Med, 33, pp. 1-3, (2008)
[6] Demura Y., Tsuchida T., Uesaka D., Umeda Y., Morikawa M., Ameshima S., Et al., Usefulness of 18 F-fluorodeoxyglucose positron emission tomography for diagnosing disease activity and monitoring therapeutic response in patients with pulmonary mycobacteriosis, Eur J Nucl Med Mol Imaging, 36, pp. 632-639, (2009)
[7] Sanabe N., Ikematsu Y., Nishiwaki Y., Kida H., Murohisa G., Ozawa T., Et al., Pancreatic tuberculosis, J Hepatobiliary Pancreat Surg, 9, pp. 515-518, (2002)
[8] Metser U., Even-Sapir E., Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT, Semin Nucl Med, 37, pp. 206-222, (2007)
[9] Goo J.M., Im J.G., Do K.H., Yeo J.S., Seo J.B., Kim H.Y., Et al., Pulmonary tuberculoma evaluated by means of FDG PET: findings in 10 cases, Radiology, 216, pp. 117-121, (2000)
[10] Yago Y., Yukihiro M., Kuroki H., Katsuragawa Y., Kubota K., Cold tuberculous abscess identified by FDG PET, Ann Nucl Med, 19, pp. 515-518, (2005)

← 1 2 →